Evangelini Dimou
About
In The Last Decade
Evangelini Dimou
12 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 44
- Epidemiology 1.1k
- Hepatology 1.1k
- Infectious Diseases 209
- Molecular Biology 60
- Oncology 25
Countries citing papers authored by Evangelini Dimou
This map shows the geographic impact of Evangelini Dimou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelini Dimou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelini Dimou more than expected).
Fields of papers citing papers by Evangelini Dimou
This network shows the impact of papers produced by Evangelini Dimou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelini Dimou. The network helps show where Evangelini Dimou may publish in the future.
Co-authorship network of co-authors of Evangelini Dimou
This figure shows the co-authorship network connecting the top 25 collaborators of Evangelini Dimou. A scholar is included among the top collaborators of Evangelini Dimou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evangelini Dimou. Evangelini Dimou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 260 | |
| 2 | The role of entecavir in the treatment of chronic hepatitis B. | 15 |
| 3 | 5 | |
| 4 | 151 | |
| 5 | 166 | |
| 6 | 11 | |
| 7 | Therapeutic administration of pegfilgrastim instead of prophylactic use. | 4 |
| 8 | 169 | |
| 9 | 115 | |
| 10 | 2 | |
| 11 | 295 | |
| 12 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.